IN THE SUPREME COURT OF THE STATE OF DELAWARE
F.A.M.E. LLC d/b/a Falk Associates § Management Enterprises a/k/a FAME, § No. 230, 2025 § Plaintiff Below, § Court Below: Superior Court Appellant/Cross-Appellee, § of the State of Delaware § v. § C.A. No. N22C-12-003 § EMTURN LLC and EVAN TURNER, § § Defendants Below, § Appellees/Cross-Appellant. §
Submitted: January 28, 2026 Decided: April 20, 2026
Before SEITZ, Chief Justice; VALIHURA, and GRIFFITHS, Justices.
Upon appeal from the Superior Court. AFFIRMED IN PART, REVERSED IN PART, AND REMANDED.
Andrew S. Dupre, Esquire (argued), Brian R. Lemon, Esquire, Alberto E. Chávez, Esquire, AKERMAN LLP, Wilmington, Delaware for Plaintiff-Below/Appellant and Cross-Appellee, F.A.M.E. LLC.
S. Mark Hurd, Esquire (argued), Alexandra M. Cumings, Esquire, MORRIS, NICHOLS, ARSHT & TUNNELL LLP, Wilmington, Delaware; James D. Curphey, Esquire, Kyle C. Gilliam, Esquire, PORTER WRIGHT MORRIS & ARTHUR LLP, Columbus, Ohio for Defendants-Below/Appellees and Cross-Appellants EmTurn LLC and Evan Turner. SEITZ, Chief Justice:
A professional basketball player’s agent secured a lucrative endorsement
contract for the player with a sportswear and sports equipment company. Part of the
player’s compensation was paid in company stock. Five years after the player
terminated the agent, the player sold some of the stock. The agent sought a
commission on the stock based on its value when sold. After the player refused to
pay, the parties took their dispute to the Superior Court.
Following cross-motions for summary judgment, the court granted the
player’s motion. It held that the stock was commissionable, but the commission was
due when the stock vested at various dates from 2011-2016 and not when the stock
was sold. Suit was not filed until 2022, outside the three-year statute of limitations.
On appeal, the agent argues that the court erred by granting the player’s
summary judgment motion because there was a genuine issue of material fact about
when the commission was due and therefore whether the statute of limitations barred
the claims. The player cross-appeals the court’s ruling that the stock was
commissionable. For the reasons explained below, we agree with the Superior Court
that the stock was commissionable but reverse its statute of limitations ruling
because genuine issues of material fact existed about when the commission was due.
2 I.
A.
Evan Turner was a professional basketball player who started his career with
the Philadelphia 76ers. Early in his career, Turner shook hands with David Falk, a
prominent sports agent, on an agency agreement. They agreed that Falk’s agency,
FAME, would represent Turner and receive a commission-based marketing fee
based on leads generated by FAME.1
FAME negotiated, and Turner’s company, EmTurn, LLC, signed an August
23, 2010 endorsement agreement with Chinese sportswear and sports equipment
companies Li-Ning Sports Technology Development (HK) Co. Limited and Li-Ning
Sports USA (“Li-Ning”). In exchange for Turner’s promotional activities, Li-Ning
agreed to compensate EmTurn in four ways: (i) guaranteed minimum cash
compensation; (ii) cash royalties based on Turner’s signature product line; (iii) cash
bonuses based on Turner’s on court accomplishments; and (iv) one million shares of
Li-Ning restricted stock.2 The Li-Ning stock vested over time starting in 2011 and
ending in 2016.3
1 App. to Appellant’s Opening Br. A34 [hereinafter “A”__] (First Am. Compl. ¶¶ 19–20). 2 A744–47 (Li-Ning Contract § 4). 3 A764 (Li-Ning Contract Schedule C).
3 On August 31, 2010, EmTurn and FAME reduced their handshake deal to
writing (“2010 Agreement”).4 The 2010 Agreement provided that FAME would
receive a 15% marketing fee “on all marketing income from leads initially generated
by FAME.”5 The marketing fee increased to 20% if marketing income exceeded $2
million in any year.6 Although “marketing income” was not defined, the 2010
Agreement stated that “FAME shall receive its Marketing Fee, as defined in this
paragraph, from any and all Marketing Contracts finalized by FAME during the
Term of this Agreement, regardless of when [EmTurn] receives compensation for
such contracts.”7 Neither party disputes that the Li-Ning endorsement agreement
fell under the 2010 Agreement.
Over time, EmTurn paid FAME marketing fees on the minimum cash
compensation, royalties, and bonuses when EmTurn received payment from Li-
Ning. Typically, Turner’s banker Stephen Vujevich would notify FAME that
EmTurn had received compensation from Li-Ning. FAME would then invoice
EmTurn for its marketing fee. Although FAME was aware of the Li-Ning stock’s
vesting schedule, it never invoiced EmTurn for a marketing fee. Falk testified that
4 A773–74 (2010 Agreement). 5 A773 (2010 Agreement). 6 Id. 7 Id.
4 when it came to the stock compensation, he did not require EmTurn to pay a cash
commission until Turner realized a liquidation event.8 In other words, when EmTurn
received cash for the Li-Ning stock, FAME would invoice and was due a
commission.
In May 2016, before Turner sold any Li-Ning stock, Turner ended his contract
with FAME.9 Between August 2021 and October 2023, Turner sold 839,600 shares
of Li-Ning stock with a total value of $7,222,863.30.10 FAME claimed that it first
learned of these sales in early 2022.11 In July of that year, FAME invoiced Turner
for a marketing fee on the Li-Ning stock sales.12 When Turner refused to pay, FAME
filed this action on December 1, 2022.
B.
In its Superior Court complaint, FAME alleged breach of contract and other
claims against EmTurn and Turner for failing to pay the marketing fee on the Li-
Ning stock sales. For ease of reference, we will refer to Turner and his company as
EmTurn. EmTurn denied the breach and raised other defenses, including a statute
8 See A232 (Dep. of David Falk at 79:1–22). 9 See A705–06 (May 25, 2016 Email From David Falk to Evan Turner). 10 A79 (Defs.’ Fourth Am. Objections and Answers to Pl’s. First Set of Interrogatories at 29). 11 A275 (Dep. of David Falk at 250:7–13). 12 See A776 (FAME EmTurn Acct. Ledger).
5 of limitations defense. After discovery, the Superior Court granted EmTurn’s motion
for summary judgment, dismissing FAME’s case in its entirety.13
First, the court found that, under the 2010 Agreement, the Li-Ning stock
qualified as “marketing income” “such that it [fell] within Turner’s obligation to pay
FAME a Marketing Fee.”14 According to the court, EmTurn was obligated to
compensate FAME “on all marketing income . . . from any and all Marketing
Contracts.”15 The court relied on the fact that “Delaware courts have held ‘all means
all’ when interpreting a contract.”16 The Li-Ning endorsement agreement qualified
as a marketing contract. Therefore, the Li-Ning stock paid to EmTurn for Turner’s
endorsements qualified as marketing income.
On the stock payment timing issue, the court decided that the 2010 Agreement
was “silent,” and thus, “ambiguous regarding when payment [was] due.”17 Looking
to the parties’ course of performance to resolve the ambiguity, the Superior Court
found that the “Defendants paid commission on the Li-Ning Contract, when Li-Ning
13 F.A.M.E. LLC v. EmTurn LLC, 2025 WL 1218227, at *1 (Del. Super. Apr. 25, 2025) [hereinafter Super. Ct. Op.]. 14 Id. at *4. 15 Id. at *5 (quoting 2010 Agreement at 1). 16 Id. at *5 (quoting Eagle Force Holdings, LLC v.
Free access — add to your briefcase to read the full text and ask questions with AI
IN THE SUPREME COURT OF THE STATE OF DELAWARE
F.A.M.E. LLC d/b/a Falk Associates § Management Enterprises a/k/a FAME, § No. 230, 2025 § Plaintiff Below, § Court Below: Superior Court Appellant/Cross-Appellee, § of the State of Delaware § v. § C.A. No. N22C-12-003 § EMTURN LLC and EVAN TURNER, § § Defendants Below, § Appellees/Cross-Appellant. §
Submitted: January 28, 2026 Decided: April 20, 2026
Before SEITZ, Chief Justice; VALIHURA, and GRIFFITHS, Justices.
Upon appeal from the Superior Court. AFFIRMED IN PART, REVERSED IN PART, AND REMANDED.
Andrew S. Dupre, Esquire (argued), Brian R. Lemon, Esquire, Alberto E. Chávez, Esquire, AKERMAN LLP, Wilmington, Delaware for Plaintiff-Below/Appellant and Cross-Appellee, F.A.M.E. LLC.
S. Mark Hurd, Esquire (argued), Alexandra M. Cumings, Esquire, MORRIS, NICHOLS, ARSHT & TUNNELL LLP, Wilmington, Delaware; James D. Curphey, Esquire, Kyle C. Gilliam, Esquire, PORTER WRIGHT MORRIS & ARTHUR LLP, Columbus, Ohio for Defendants-Below/Appellees and Cross-Appellants EmTurn LLC and Evan Turner. SEITZ, Chief Justice:
A professional basketball player’s agent secured a lucrative endorsement
contract for the player with a sportswear and sports equipment company. Part of the
player’s compensation was paid in company stock. Five years after the player
terminated the agent, the player sold some of the stock. The agent sought a
commission on the stock based on its value when sold. After the player refused to
pay, the parties took their dispute to the Superior Court.
Following cross-motions for summary judgment, the court granted the
player’s motion. It held that the stock was commissionable, but the commission was
due when the stock vested at various dates from 2011-2016 and not when the stock
was sold. Suit was not filed until 2022, outside the three-year statute of limitations.
On appeal, the agent argues that the court erred by granting the player’s
summary judgment motion because there was a genuine issue of material fact about
when the commission was due and therefore whether the statute of limitations barred
the claims. The player cross-appeals the court’s ruling that the stock was
commissionable. For the reasons explained below, we agree with the Superior Court
that the stock was commissionable but reverse its statute of limitations ruling
because genuine issues of material fact existed about when the commission was due.
2 I.
A.
Evan Turner was a professional basketball player who started his career with
the Philadelphia 76ers. Early in his career, Turner shook hands with David Falk, a
prominent sports agent, on an agency agreement. They agreed that Falk’s agency,
FAME, would represent Turner and receive a commission-based marketing fee
based on leads generated by FAME.1
FAME negotiated, and Turner’s company, EmTurn, LLC, signed an August
23, 2010 endorsement agreement with Chinese sportswear and sports equipment
companies Li-Ning Sports Technology Development (HK) Co. Limited and Li-Ning
Sports USA (“Li-Ning”). In exchange for Turner’s promotional activities, Li-Ning
agreed to compensate EmTurn in four ways: (i) guaranteed minimum cash
compensation; (ii) cash royalties based on Turner’s signature product line; (iii) cash
bonuses based on Turner’s on court accomplishments; and (iv) one million shares of
Li-Ning restricted stock.2 The Li-Ning stock vested over time starting in 2011 and
ending in 2016.3
1 App. to Appellant’s Opening Br. A34 [hereinafter “A”__] (First Am. Compl. ¶¶ 19–20). 2 A744–47 (Li-Ning Contract § 4). 3 A764 (Li-Ning Contract Schedule C).
3 On August 31, 2010, EmTurn and FAME reduced their handshake deal to
writing (“2010 Agreement”).4 The 2010 Agreement provided that FAME would
receive a 15% marketing fee “on all marketing income from leads initially generated
by FAME.”5 The marketing fee increased to 20% if marketing income exceeded $2
million in any year.6 Although “marketing income” was not defined, the 2010
Agreement stated that “FAME shall receive its Marketing Fee, as defined in this
paragraph, from any and all Marketing Contracts finalized by FAME during the
Term of this Agreement, regardless of when [EmTurn] receives compensation for
such contracts.”7 Neither party disputes that the Li-Ning endorsement agreement
fell under the 2010 Agreement.
Over time, EmTurn paid FAME marketing fees on the minimum cash
compensation, royalties, and bonuses when EmTurn received payment from Li-
Ning. Typically, Turner’s banker Stephen Vujevich would notify FAME that
EmTurn had received compensation from Li-Ning. FAME would then invoice
EmTurn for its marketing fee. Although FAME was aware of the Li-Ning stock’s
vesting schedule, it never invoiced EmTurn for a marketing fee. Falk testified that
4 A773–74 (2010 Agreement). 5 A773 (2010 Agreement). 6 Id. 7 Id.
4 when it came to the stock compensation, he did not require EmTurn to pay a cash
commission until Turner realized a liquidation event.8 In other words, when EmTurn
received cash for the Li-Ning stock, FAME would invoice and was due a
commission.
In May 2016, before Turner sold any Li-Ning stock, Turner ended his contract
with FAME.9 Between August 2021 and October 2023, Turner sold 839,600 shares
of Li-Ning stock with a total value of $7,222,863.30.10 FAME claimed that it first
learned of these sales in early 2022.11 In July of that year, FAME invoiced Turner
for a marketing fee on the Li-Ning stock sales.12 When Turner refused to pay, FAME
filed this action on December 1, 2022.
B.
In its Superior Court complaint, FAME alleged breach of contract and other
claims against EmTurn and Turner for failing to pay the marketing fee on the Li-
Ning stock sales. For ease of reference, we will refer to Turner and his company as
EmTurn. EmTurn denied the breach and raised other defenses, including a statute
8 See A232 (Dep. of David Falk at 79:1–22). 9 See A705–06 (May 25, 2016 Email From David Falk to Evan Turner). 10 A79 (Defs.’ Fourth Am. Objections and Answers to Pl’s. First Set of Interrogatories at 29). 11 A275 (Dep. of David Falk at 250:7–13). 12 See A776 (FAME EmTurn Acct. Ledger).
5 of limitations defense. After discovery, the Superior Court granted EmTurn’s motion
for summary judgment, dismissing FAME’s case in its entirety.13
First, the court found that, under the 2010 Agreement, the Li-Ning stock
qualified as “marketing income” “such that it [fell] within Turner’s obligation to pay
FAME a Marketing Fee.”14 According to the court, EmTurn was obligated to
compensate FAME “on all marketing income . . . from any and all Marketing
Contracts.”15 The court relied on the fact that “Delaware courts have held ‘all means
all’ when interpreting a contract.”16 The Li-Ning endorsement agreement qualified
as a marketing contract. Therefore, the Li-Ning stock paid to EmTurn for Turner’s
endorsements qualified as marketing income.
On the stock payment timing issue, the court decided that the 2010 Agreement
was “silent,” and thus, “ambiguous regarding when payment [was] due.”17 Looking
to the parties’ course of performance to resolve the ambiguity, the Superior Court
found that the “Defendants paid commission on the Li-Ning Contract, when Li-Ning
13 F.A.M.E. LLC v. EmTurn LLC, 2025 WL 1218227, at *1 (Del. Super. Apr. 25, 2025) [hereinafter Super. Ct. Op.]. 14 Id. at *4. 15 Id. at *5 (quoting 2010 Agreement at 1). 16 Id. at *5 (quoting Eagle Force Holdings, LLC v. Campbell, 187 A.3d 1209, 1233 (Del. 2018)). 17 Id. at *7.
6 compensated Turner.”18 According to the court, because there was “no evidence
FAME ever objected to this arrangement” and “there [was] no dispute that
Defendants received the Stock at vesting,” the court concluded that the claim “arose
when the Stock vested.”19
Further, relying on dictionary definitions, the court found FAME’s position –
that the marketing fee became payable when EmTurn sold the Li-Ning stock –
inconsistent with the 2010 Agreement:
Income is generally defined as money that is earned from doing work. Marketing is defined as a job that involves encouraging people to buy a product or services. Upon vesting, Turner received the Stock as payment for his efforts encouraging people to buy Li-Ning shoes. At that point, the Stock was marketing income and FAME could invoice a Marketing Fee. Conversely, the money Turner received from the Stock sale was not due to any marketing efforts.20
The last of the Li-Ning stock vested on July 1, 2016. A three-year statute of
limitations applied. Because the complaint was not filed until December 1, 2022,
the Superior Court dismissed FAME’s claims as time barred.
II.
On appeal, EmTurn argues that the Superior Court erred by concluding that
the 2010 Agreement unambiguously provided that the Li-Ning stock was
18 Id. 19 Id. 20 Id. (cleaned up).
7 commissionable. According to EmTurn, the 2010 Agreement did not address how
to treat stock compensation. Therefore, it argues, the court should have applied
contra proferentem, meaning it should have interpreted the agreement against
FAME, the party who drafted it, and dismissed the complaint.
FAME argues that the Superior Court erred in granting EmTurn’s summary
judgment motion because a factual dispute existed about the parties’ course of
performance with respect to when payment was due for stock compensation. FAME
points out that EmTurn did not offer course of performance evidence specific to
stock compensation. Moreover, FAME contends that the course of performance
evidence relied on by the court was subject to more than one reasonable
interpretation. Thus, it argues, the court could have also concluded that the
marketing fee was due when EmTurn sold the Li-Ning stock, not when the stock
vested. Therefore, the statute of limitations did not bar recovery.
On appeal, “[w]e review the Superior Court’s grant of summary judgment de
novo. We review questions of contract interpretation de novo.”21 Under Superior
Court Rule of Civil Procedure 56, summary judgment should only be granted when
there are no genuine issues of material fact and the moving party is entitled to
judgment as a matter of law.
21 Intel Corp. v. Am. Guarantee & Liab. Ins. Co., 51 A.3d 442, 446 (Del. 2012).
8 A.
The Superior Court correctly concluded that “marketing income” in the 2010
Agreement unambiguously included the Li-Ning stock. Under the 2010 Agreement,
the Li-Ning endorsement agreement was a “lead[] initially generated by FAME” that
resulted in a “Marketing Contract[] finalized by FAME during the Term of this
Agreement.”22 In addition to three other listed forms of cash compensation, Li-Ning
agreed to pay EmTurn Li-Ning stock for Turner’s endorsements.23
EmTurn argues that, even though the Li-Ning stock was one of four forms of
compensation in the 2010 Agreement, the lack of payment mechanisms for stock
compensation means it was not commissionable.24 We have some difficulty
understanding the argument. Under the 2010 Agreement, FAME received a
percentage of all remuneration EmTurn received from leads FAME generated that
led to an endorsement contract. The stock was one of four forms of compensation
specified in the Li-Ning endorsement agreement.25 The lack of payment
22 A773 (2010 Agreement). 23 A744–46 (Li-Ning Contract § 4). 24 Answering Br. 29 (the “mechanisms” are those that “one would expect to see in agreement for fee on stock” and include how to value the stock, determine when the commission is owed, and determine the form the commission is to be paid). There were, of course, details missing with respect to the cash compensation EmTurn received from Li-Ning as well. 25 EmTurn’s reliance on Merck & Co. v. Bayer AG is off the mark. 2023 WL 2751590 (Del. Ch. Apr. 3, 2023), aff’d, 308 A.3d 1190 (Del. 2023) (TABLE). Merck addressed how to interpret a pharmaceutical industry purchase agreement. The Court of Chancery found that because liability for certain product liability claims remained with the seller, the seller’s interpretation of the 9 mechanisms or due dates may require the court to imply omitted terms, but it does
not call into question whether the Li-Ning stock was commissionable.
Further, the term “marketing income” is not ambiguous “simply because it is
not defined.”26 The Superior Court gave the words their plain meaning – any
remuneration EmTurn received as compensation from endorsement agreements.27
EmTurn was paid Li-Ning stock to compensate it for Turner’s endorsements. And
if there was any remaining doubt, we need only look to a dictionary definition of
income – “[t]he money or other form of payment that one receives . . . from
employment, business, investments, royalties, gifts, and the like.”28 The Li-Ning
stock was an “other form of payment” from Li-Ning for Turner’s endorsements.
indemnification provision, which would have its liability essentially sunset after seven years, was an “absurd conclusion” given that there was “no mechanism” in the purchase agreement to transfer them to buyer. Id. at *9. Here, interpreting marketing income to include the Li-Ning stock despite the lack of payment “mechanisms” neither conflicts with other provisions of the contract nor causes an “absurd” result. 26 Zurich Am. Ins. Co. v. Syngenta Crop Prot. LLC, 314 A.3d 665, 676 (Del. 2024) (“A term is not ambiguous simply because it is not defined[.]” (quoting 1 Bradley W. Voss, Voss on Delaware Contract Law § 3.06 [2][j] at 3-35 (Jan. 2023))). 27 Super. Ct. Op. at *5. See Norton v. K-Sea Transp. Partners L.P., 67 A.3d 354, 360 (Del. 2013) (the court should give contract terms their “plain meaning unless it appears that the parties intended a special meaning”). 28 Income, Black’s Law Dictionary (12th ed. 2024) (emphasis added). See Lorillard Tobacco Co. v. Am. Legacy Fdn., 903 A.2d 728, 740 (Del. 2006) (“When a term’s definition is not altered or has ‘no ‘gloss’ in the [relevant] industry it should be construed in accordance with its ordinary dictionary meaning.’” (alteration in original) (quoting USA Cable v. World Wrestling Fed’n Entm’t, Inc., 766 A.2d 462, 474 (Del. 2000))).
10 B.
Having found the Li-Ning stock commissionable, the next issue is whether
FAME’s breach of contract claim against EmTurn is barred by the statute of
limitations. Typically, a three-year statute of limitations applies to breach of contract
claims.29 The statute begins to run when the contract is breached, meaning when
payment is due.30
Although the parties framed the contractual dispute as a search for the
meaning of an ambiguous term, they failed to distinguish between contractual
silence, when the contract does not address the issue, and ambiguity, when contract
language is susceptible of different reasonable interpretations.31 The 2010
Agreement had a missing term – when were commission payments due?32 Where,
29 10 Del. C. § 8106. 30 Chertok v. Zillow, Inc., 2021 WL 4851816, at *6–7 (Del. Ch. Oct. 18, 2021) (dismissing breach of contract claims alleging failure to make pre-closing dividend payments as time-barred because complaint was filed more than three years after plaintiffs’ “entitlement to the dividend payments arose”), aff’d, 277 A.3d 1258 (Del. 2022) (TABLE). 31 We do not fault the Superior Court for following the lead of the parties and undertaking an ambiguity analysis. 32 See Murr v. Midland Nat. Life Ins. Co., 758 F.3d 1016, 1020 n.4 (8th Cir. 2014) (“[w]hen a term is missing, however, there is nothing to interpret or to find ambiguous”); Nissho Iwai Europe PLC v. Korea First Bank, 782 N.E.2d 55, 60 (N.Y. 2002) (“[A]s with all written agreements . . . ambiguity does not arise from silence, but from ‘what was written so blindly and imperfectly that its meaning is doubtful.’” (quotation omitted)); Restatement (Second) of Contracts § 204 (1981) (“When the parties to a bargain sufficiently defined to be a contract have not agreed with respect to a term which is essential to a determination of their rights and duties, a term which is reasonable in the circumstances is supplied by the court.”); see also AR Cap., LLC v. Xl Specialty Ins. Co., 11 as here, the contract does not provide the time for payment, “the court will imply a
reasonable time.”33 Ordinarily, questions like what is a reasonable time for payment
cannot be resolved on summary judgment because the factfinder must assess “prior
dealings of the parties, the practice in the relevant community and trade or business
and other circumstances surrounding the execution and performance of the
contract.”34 As explained next, that is the case here.
1.
The parties agree, and their course of performance confirms, that commissions
on cash compensation were paid when EmTurn received payment. According to the
parties, for stock compensation, there were two possibilities when a commission
2018 WL 6601184, at *6 (Del. Super. Dec. 12, 2018) (observing that “provisions not included in an agreement are not equivalent to ambiguous terms”). 33 Martin v. Star Pub. Co., 126 A.2d 238, 244 (Del. 1956); HIFN, Inc. v. Intel Corp., 2007 WL 1309376, at *11 n.96 (Del. Ch. May 2, 2007) (“When time is not of the essence, the UCC and the common law of contracts both require performance within a reasonable time.”); Comet Sys., Inc. S’holders’ Agent v. MIVA, Inc., 980 A.2d 1024, 1034–35 (Del. Ch. 2008) (where stockholders were entitled to earnout payment under a merger agreement, but the agreement lacked “a provision requiring payment on a specific date,” there is an implied “duty to make payment on that obligation within a reasonable time”); Alonso v. Maldonado, 2015 WL 7068206, at *2 (Del. Super. Nov. 12, 2015) (inferring a reasonable time for repayment on loan agreement which did not include payment date term and holding that the statute of limitations did not bar recovery where suit was filed within three years of that time). EmTurn acknowledges in its appellate briefing that: “[u]nder Delaware law, ‘[w]here a contract is silent on the time given to a party to perform a condition, then this Court will assume that the parties contemplated a reasonable time.’” Answering Br. 24 (first alteration added) (quoting White v. Russell, 2023 WL 3191746, at *6 (Del. Ch. May 2, 2023)). 34 Dechant v. Williams, 1990 WL 1104786, at *2 (Del. Ch. 1990) (denying summary judgment when contract required performance within “a reasonable time”); see also HIFN, Inc., 2007 WL 1309376, at *11 (observing that what constitutes “a reasonable time is ordinarily a question of fact and thus often inappropriate for resolution at the summary judgment stage”).
12 payment was due – when the shares vested, and when EmTurn sold the Li-Ning
stock. The summary judgment record supports EmTurn’s view that a commission
was owed when the Li-Ning stock vested. As EmTurn argued, if there is no deadline
for payment of a fee on stock, then EmTurn could hold the Li-Ning stock forever.
And it points to treasury regulations addressing when capital gains or losses are
recognized, and the fact that EmTurn paid taxes when the stock vested. Thus,
EmTurn argues, it makes sense that a commission payment was due when the Li-
Ning stock vested.
But viewing the summary judgment record in a light most favorable to
FAME, the summary judgment record and course of performance evidence supports
another conclusion – a reasonable time for the commission payment was when
EmTurn received cash from the sale of stock to pay the commission. The parties did
not address the payment timing issue at or before the time of contracting. After
signing the 2010 Agreement, FAME never invoiced EmTurn for a commission on
the Li-Ning stock until EmTurn had cash to pay the commission. In June 2016,
FAME emailed EmTurn’s accountant stating that EmTurn was about to receive the
last of its Li-Ning stock and that the parties needed “to determine when [Turner] will
sell these shares and pay FAME its 20% fee of their value.”35 And, as the Superior
35 A802 (June 16, 2016 Email From FAME to Stephen Vujevich). The Superior Court also relied on deposition testimony by EmTurn’s accountant, Stephen Vujevich. See Super. Ct. Op. at *7 n.107. Vujevich’s testimony, however, was inconclusive. He testified that EmTurn had not 13 Court observed, “FAME always invoiced its Marketing Fees when [EmTurn]
actually received cash compensation.”36
Further, looking at business custom and usage in the sports agency industry,
Falk testified that taking a cash commission at the time of vesting would be “one of
the dumbest things possible for an agent to do.”37 He explained:
My job is to build trust with my clients. I take every step I can to build trust to let them know that I’m not going to put my own personal interest ahead of their interest. And so it would be almost suicidal for an agent to bill a player when the stock vest[s], in the event it goes down, you are going to get fired because it looks like you are putting your own interest ahead of the player’s, you [are] trying to get the fee early.38
We conclude that genuine issues of material fact existed about a reasonable
time for paying FAME a commission on the Li-Ning stock. The statute of limitations
accrual date depends on resolving the payment date. Thus, summary judgment
should not have been granted to EmTurn.
historically disputed FAME’s invoices, which he received after EmTurn was paid “actual money” from Li-Ning. A548, A556 (Dep. of Stephen Vujevich at 49:9–14, 78:17–20). 36 Super. Ct. Op. at *6 (emphasis added). 37 A232 (Dep. of David Falk at 79:9–10). 38 A232 (Dep. of David Falk at 80:12–21).
14 2.
EmTurn argues that the Superior Court held, on an alternative basis, that
FAME’s position was inconsistent with the 2010 Agreement. According to EmTurn,
the court reasoned that the Li-Ning stock was payment for Turner’s marketing
efforts; when EmTurn received the vested shares, FAME could invoice for the
marketing fee; and after that, the money EmTurn received from selling its Li-Ning
stock came from non-marketing capital gains/losses and not from any marketing
efforts.
If we accepted EmTurn’s view of the Superior Court’s ruling, it would be
inconsistent with the court’s earlier finding that the 2010 Agreement was
“ambiguous” – meaning more than one reasonable interpretation existed about when
the commission was due. In any event, as we have reframed the dispute, the 2010
Agreement did not address when payment was due. The 2010 Agreement could not,
therefore, control as a matter of law when a commission payment was due on the Li-
Ning stock.
III.
The judgment of the Superior Court is affirmed in part and reversed in part.
The case is remanded for further proceedings consistent with this opinion. On
remand, the fact finder should decide what was a reasonable time to pay the
15 commission on the Li-Ning stock – at the time of vesting, or at the time of sale. The
answer will dictate the outcome of the statute of limitations issue.